Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg
Veterans Administration Cooperative Study on Anti-hypertensive Agents: Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:1028-1034.
Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for hypertension
Veterans Administration Cooperative Study on Anti-hypertensive Agents: Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for hypertension. Am J Cardiol 1983;52:1230-1237.
Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial
Veterans Administration Cooperative Study on Anti-hypertensive Agents: Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Arch Intern Med 1984;144:1947-1953.
Low doses vs. standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone
Participating Veterans Administration Medical Centers: Low doses vs. standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone. JAMA 1982;248:2471-2477.
Propranolol in the treatment of essential hypertension
Veterans Administration Cooperative Study on Anti-hypertensive Agents: Propranolol in the treatment of essential hypertension. JAMA 1977;237:2303-2310.
Single-drug therapy for hypertension in men; a comparison of six antihypertensive agents with placebo
Materson BJ, Reda DJ, Cushman WC, et al: Single-drug therapy for hypertension in men; a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
Results of combination of anti-hypertensive therapy after failure of each of the components
Materson BJ, Reda DJ, Cushman WC, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents: Results of combination of anti-hypertensive therapy after failure of each of the components. J Human Hypertens 1995; 9:791-796.
Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug
Materson BJ, Reda DJ, Preston RA, et al: Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Arch Intern Med 1995;155:1757-1762.